Bluebee was founded in 2011 by an international team from the leading universities Delft University of Technology (the Netherlands) and Imperial College London (United Kingdom). BlueBee offers a secure global bioinformatics platform to process, analyze, share and store genomics data. BlueBee develops tailor-made data solutions that are ISO 13485 and ISO 27001 accredited and meeting GDPR and other global compliance requirements, for diagnostic assay manufacturers and service laboratories running high-throughput genomic assays. BlueBee supports end users in clinical diagnostics, therapeutics, and research with a shared mission—to power precision medicine.
investment / exit